Yorke Justin W. - 21 Nov 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
21 Nov 2023
Net transactions value
$0
Form type
4
Filing time
28 Nov 2023, 16:13:39 UTC
Previous filing
23 Oct 2023
Next filing
31 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Other $0 -55,267 -11% $0.000000 464,623 21 Nov 2023 By Richland Fund, LLC F1
holding PCSA Common Stock 74,729 21 Nov 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a transfer of shares to a fund that the Reporting Person does not manage. As a result, the reporting person is no longer deemed to be the beneficial owner of such shares.